Petat H, Schuers M, Rabiaza A, Marguet C, Pellerin L, Le Bas F, Humbert X, Corbet S, Deseille B, Gosse L, Lambert P-A, Poupon T, Vervisch E, Morello R, Chaillot F, Ecovir M, Vabret A, Le Gouil M
Groupe de recherche sur l'adaptation microbienne (GRAM 2.0), Normandie université, UNICAEN, UNIROUEN, EA2656, 14033 Caen, France; Laboratoire de virologie, centre hospitalo-universitaire, 14033 Caen, France; Département de pédiatrie médicale, centre hospitalier universitaire de Rouen, EA2656 université de Normandie, UNIRouen, 76000 Rouen, France.
Normandie université, UFR Santé Rouen, département de médecine générale, 76000 Rouen, France; Inserm, U1142, laboratoire d'informatique médicale et d'ingénierie des connaissances en e-Santé, LIMICS, Sorbonne université, Paris, France.
Rev Mal Respir. 2022 Apr;39(4):334-343. doi: 10.1016/j.rmr.2022.02.060. Epub 2022 Mar 3.
Acute Respiratory Infections (ARI) need be better understood and more effectively treated, especially insofar as they are of pivotal importance in public health, particularly during a crisis such as the SARS-CoV2 pandemic. The prospective, multicentric cohort study of viral codetections in respiratory samples study known as ECOVIR was conducted in Normandy, France during two winters (2018-2019, 2019-2020). The objective of the project was to create a biobank of respiratory tract samples from patients consulting their general practitioner (GP) for ARI symptoms. ECOVIR involved 36 GP investigators (GPI), from 8 health care centers throughout Normandy. Six hundred and eighty-five patients with ARI symptoms were included; naso-pharyngeal samples were taken by the GPIs and subsequently analyzed in virology laboratories for the purposes of viral codetection. The median of inclusions was 16 patients for each of the 31 actively participating GPIs over the two winters (CI25-75% [4.75; 27]). By D7, 92% of the patients contacted had responded to our call for participation, enabling us to obtain clinical, environmental and socio-demographic data. Through this study, we created an original functional network, thereby establishing a viable link between research and primary care, which is generally underrepresented in research protocols, even though it constitutes the cornerstone of the French health care system, especially during this prolonged period of sanitary crisis.
急性呼吸道感染(ARI)需要得到更好的理解和更有效的治疗,尤其是考虑到它们在公共卫生中至关重要,特别是在诸如SARS-CoV2大流行这样的危机期间。一项名为ECOVIR的关于呼吸道样本中病毒联合检测的前瞻性、多中心队列研究于两个冬季(2018 - 2019年、2019 - 2020年)在法国诺曼底进行。该项目的目标是建立一个生物样本库,收集因ARI症状咨询全科医生(GP)的患者的呼吸道样本。ECOVIR项目涉及来自诺曼底各地8个医疗中心的36名全科医生研究者(GPI)。纳入了685名有ARI症状的患者;GPI采集了鼻咽样本,随后在病毒学实验室进行分析以进行病毒联合检测。在这两个冬季,31名积极参与的GPI中,每个GPI纳入患者的中位数为16名(25 - 75%置信区间[4.75;27])。到第7天,92%被联系的患者对我们的参与邀请做出了回应,使我们能够获取临床、环境和社会人口统计学数据。通过这项研究,我们创建了一个原创的功能网络,从而在研究与初级医疗之间建立了一个可行的联系,尽管初级医疗是法国医疗体系的基石,尤其是在这段长期的卫生危机期间,但在研究方案中它通常代表性不足。